Approval · Notice of Compliance 16556 · 2015
20% PROSOL: Notice of Compliance 16556
Issued January 22, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16556
- Date
- January 22, 2015
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Therapeutic class
- Nutritive supplement
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| 20% PROSOL | 02141450 | Marketed |
Medicinal ingredients
- L-ALANINE 2.76 G per 100ML
- L-ASPARTIC ACID 0.6 G per 100ML
- GLYCINE 2.06 G per 100ML
- L-ARGININE 1.96 G per 100ML
- L-GLUTAMIC ACID 1.02 G per 100ML
- L-HISTIDINE 1.18 G per 100ML
- L-ISOLEUCINE 1.08 G per 100ML
- L-LEUCINE 1.08 G per 100ML
- L-PHENYLALANINE 1 G per 100ML
- L-PROLINE 1.34 G per 100ML
- L-SERINE 1.02 G per 100ML
- L-THREONINE 0.98 G per 100ML
- L-TRYPTOPHAN 0.32 G per 100ML
- L-VALINE 1.44 G per 100ML
- LYSINE ACETATE 1.35 G per 100ML
- DL-METHIONINE 0.76 G per 100ML
- L-TYROSINE 0.05 G per 100ML